Epilepsy / nicotina

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Solo gli utenti registrati possono tradurre articoli

Entra registrati

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Solo gli utenti registrati possono tradurre articoli

Entra registrati

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Solo gli utenti registrati possono tradurre articoli

Entra registrati

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Solo gli utenti registrati possono tradurre articoli

Entra registrati

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Solo gli utenti registrati possono tradurre articoli

Entra registrati

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

5-HT.sub.2C receptor agonists and compositions and methods of use

Solo gli utenti registrati possono tradurre articoli

Entra registrati

Obesity is a life-threatening disorder in which there is an increased risk of morbidity and mortality arising from concomitant diseases such as type II diabetes, hypertension, stroke, cancer, and gallbladder disease. Obesity is now a major healthcare issue in the Western World and increasingly in

5-HT.sub.2C receptor agonists and compositions and methods of use

Solo gli utenti registrati possono tradurre articoli

Entra registrati

Obesity is a life-threatening disorder in which there is an increased risk of morbidity and mortality arising from concomitant diseases such as type II diabetes, hypertension, stroke, cancer, and gallbladder disease. Obesity is now a major healthcare issue in the Western World and increasingly in

5-HT2C receptor agonists and compositions and methods of use

Solo gli utenti registrati possono tradurre articoli

Entra registrati

Obesity is a life-threatening disorder in which there is an increased risk of morbidity and mortality arising from concomitant diseases such as type II diabetes, hypertension, stroke, cancer, and gallbladder disease. Obesity is now a major healthcare issue in the Western World and increasingly in

Aminoadamantane derivatives as therapeutic agents

Solo gli utenti registrati possono tradurre articoli

Entra registrati

BACKGROUND OF THE INVENTION Certain adamantane derivatives have been used to treat illnesses. Rimantadine (1-(1-aminoethyl)adamantane) is used for the prophylaxis and treatment of influenza in humans. Amantadine has been used for the treatment of both influenza and Parkinson's disease (Schwab et

Aminoadamantane derivatives as therapeutic agents

Solo gli utenti registrati possono tradurre articoli

Entra registrati

BACKGROUND OF THE INVENTION Certain adamantane derivatives have been used to treat illnesses. Rimantadine (1-(1-aminoethyl)adamantane) is used for the prophylaxis and treatment of influenza in humans. Amantadine has been used for the treatment of both influenza and Parkinson's disease (Schwab et

Aminoadamantane derivatives as therapeutic agents

Solo gli utenti registrati possono tradurre articoli

Entra registrati

BACKGROUND OF THE INVENTION Certain adamantane derivatives have been used to treat illnesses. Rimantadine (1-(1-aminoethyl)adamantane) is used for the prophylaxis and treatment of influenza in humans. Amantadine has been used for the treatment of both influenza and Parkinson's disease (Schwab et

Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety

Solo gli utenti registrati possono tradurre articoli

Entra registrati

FIELD OF INVENTION The invention relates generally to animal model systems useful for examining and manipulating neurobehaviors mediated by nicotine. More specifically, the invention relates to knock-in mice having a leucine-to-serine mutation of the .alpha.4 nicotinic receptor subunit gene

Tryptamine sulfonamides as 5-HT.sub.6 antagonists

Solo gli utenti registrati possono tradurre articoli

Entra registrati

BACKGROUND OF THE INVENTION Serotonin (5-hydroxy-tryptamine) (5-HT) receptors play an important role in many physiological and pathological functions like anxiety, sleep regulation, aggression, feeding and depression. The 5-HT receptors are distributed throughout the body and can be divided is into

1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders

Solo gli utenti registrati possono tradurre articoli

Entra registrati

FIELD OF THE INVENTION The present invention relates to a group of 1-substituted-2-azabicyclo-[3.1.1]heptyl derivatives with biological activity. The present invention also relates to synthetic methods for producing 1-substituted-2-azabicyclo-[3.1.1]heptyl derivatives belonging to this group. The

Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions

Solo gli utenti registrati possono tradurre articoli

Entra registrati

FIELD OF THE INVENTION The present invention relates to a group of substituted-7-azabicyclo-[2.2.1]heptyl derivatives with biological activity. The present invention also relates to synthetic methods for producing substituted-7-azabicyclo-[2.2.1]heptyl derivatives belonging to this group. The

epilepsy/nicotina

5-HT.sub.2C receptor agonists and compositions and methods of use

5-HT.sub.2C receptor agonists and compositions and methods of use

5-HT2C receptor agonists and compositions and methods of use

Aminoadamantane derivatives as therapeutic agents

Aminoadamantane derivatives as therapeutic agents

Aminoadamantane derivatives as therapeutic agents

Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety

Tryptamine sulfonamides as 5-HT.sub.6 antagonists

1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders

Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions

Il database di erbe medicinali più completo supportato dalla scienza